Jason Cavalier

Insider Reports History

Entity
Individual
Location
C/O Lyra Therapeutics, Inc., 1480 Arsenal Way, Watertown, MA
Signature
/s/ Jason Cavalier
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Cavalier:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyra Therapeutics, Inc. Chief Financial Officer Stock Options 200K Jan 30, 2024 Direct
Lyra Therapeutics, Inc. Chief Financial Officer Common Stock 100K Oct 16, 2024 Direct

Insider Reports Filed by Jason Cavalier

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYRA Lyra Therapeutics, Inc. Oct 16, 2024 1 $0 4 Oct 18, 2024 Chief Financial Officer
LYRA Lyra Therapeutics, Inc. Jan 30, 2024 1 $0 4 Feb 1, 2024 Chief Financial Officer
LYRA Lyra Therapeutics, Inc. Jan 31, 2023 1 $0 4 Feb 2, 2023 Chief Financial Officer
LYRA Lyra Therapeutics, Inc. Feb 12, 2022 1 $0 4 Feb 15, 2022 Chief Financial Officer
LYRA Lyra Therapeutics, Inc. Sep 13, 2021 1 $0 4 Sep 15, 2021 Chief Financial Officer
LYRA Lyra Therapeutics, Inc. Sep 13, 2021 0 $0 3 Sep 15, 2021 Chief Financial Officer